IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Portfolio Profile

CIK: 0001606074 | SAN FRANCISCO, CA

$1.2M
AUM
7
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1NGM Biopharmaceuticals Inc(NGMUSD)18,017,932$286.7K23.39%
2Revolution Medicines Inc(RVMD)7,977,384$277.6K22.65%
3Nurix Therapeutics Inc(NRIX)6,755,881$235.8K19.24%
4Rapt Therapeutics Inc(RAPTEUR)5,630,497$181.3K14.79%
5Constellation Pharmceticls I(CNST)6,051,376$122.6K10.00%
6Oric Pharmaceuticals Inc.(ORIC)4,768,181$119.3K9.73%
7Gritstone Oncology Inc(2JQ)869,493$2.3K0.19%

Sector Allocation

Latest filing, equity positions only

Healthcare51.63% · $632.7K
Unclassified48.37% · $592.9K

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.35%51.63%-46.72%
Unclassified1.65%48.37%+46.72%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$38.2M | 8 pos.
$44.4M | 9 pos.
$28.5M | 8 pos.
$32.5M | 8 pos.
$36.6M | 7 pos.
$49.9M | 10 pos.
Cap SizePrev %Curr %Change
Unclassified1.65%48.37%+46.72%
Small Cap0.36%28.97%+28.61%
Large Cap0.56%22.65%+22.09%
Mid Cap97.43%0%-97.43%
$44.9M | 11 pos.
$1.2M | 11 pos.
Q4
18
Q1
19
Q2
19
Q3
19
Q4
19
Q1
20
Q2
20
Q3
20

Recent Activity

Quarter-over-quarter position changes

1
New
1
Closed
1
Increased
2
Decreased
3
Unchanged